Press release
July 10, 2026
Cue Biopharma Announces $50.0 Million Private Placement
Cue Biopharma, Inc. (CUE)
BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological disorders, today announced that it has entered into a securities purchase agreement